DNA extraction: An understudied and important aspect of HPV genotyping using PCR-based methods

被引:47
作者
Dunn, S. Terence
Allen, Richard A.
Wang, Sophia
Walker, Joan
Schiffman, Mark
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73190 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA
[3] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA
关键词
HPV; virus; DNA extraction; genotyping; linear array;
D O I
10.1016/j.jviromet.2007.02.006
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Testing for the group of similar to 15 carcinogenic human papillomavirus (HPV) genotypes is an important adjunct to cytology. Because carcinogenic strengths of HPV types differ greatly, assays that permit identification of individual HPV genotypes are being introduced. Most HPV genotyping systems proposed for clinical use are PCR-based, depending heavily for validity on careful attention to numerous details. One understudied detail is the effect of different sample preparation methods including DNA extraction. This study examines the influence of DNA extraction on performance of a new PCR-based genotyping kit, the Roche LINEAR ARRAY(R) HPV assay. When volume of sample extracted, DNA extraction methods and/or amount of DNA tested were varied, the HPV type results were reproducible for strong viral bands but not weak ones. Moreover, although the experiments were not comprehensive, they showed that the manufacturer-approved DNA extraction method might not be the best method for use in this assay. Because different "front end" protocols introduce variability into genotyping results, the authors urge laboratories not to vary methods for this assay without due consideration. The results suggest that companies carefully optimize DNA extraction methods prior to commercial introduction of their PCR-based genotyping assays destined for widespread clinical use. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 22 条
[1]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[2]   Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention [J].
Castellsagué, X ;
Díaz, M ;
de Sanjosé, S ;
Muñoz, N ;
Herrero, R ;
Franceschi, S ;
Peeling, RW ;
Ashley, R ;
Smith, JS ;
Snijders, PJF ;
Meijer, CJLM ;
Bosch, FX .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :303-315
[3]   Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: Comparison of HPV risk group to cytology and histology [J].
Castle, Philip E. ;
Sadorra, Mark ;
Garcia, Francisco ;
Holladay, E. Blair ;
Kornegay, Janet .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (11) :3915-3917
[4]   Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[5]   Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR [J].
D'Souza, G ;
Sugar, E ;
Ruby, W ;
Gravitt, P ;
Gillison, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (11) :5526-5535
[6]  
Dodson S, 2005, J MOL DIAGN, V7, P670
[7]   Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method [J].
Gravitt, PE ;
Peyton, CL ;
Apple, RJ ;
Wheeler, CM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :3020-3027
[8]  
International Agency for Research on Cancer (IARC) Working Group on Evaluation of Carcinogenic Risks to Humans, 2005, IARC MON EV CARC RIS
[9]   The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice [J].
Khan, MJ ;
Castle, PE ;
Lorincz, AT ;
Wacholder, S ;
Sherman, M ;
Scott, DR ;
Rush, BB ;
Glass, AG ;
Shiffman, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14) :1072-1079
[10]   Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality [J].
Kovacic, Melinda Butsch ;
Castle, Philip E. ;
Herrero, Rolando ;
Schiffman, Mark ;
Sherman, Mark E. ;
Wacholder, Sholom ;
Rodriguez, Ana C. ;
Hutchinson, Martha L. ;
Bratti, M. Concepcion ;
Hildesheim, Allan ;
Morales, Jorge ;
Alfaro, Mario ;
Burk, Robert D. .
CANCER RESEARCH, 2006, 66 (20) :10112-10119